Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 513 shares at $240.32 ($124K) on 2025-02-28, disclosed to the SEC on 2025-03-03.
Open-market sale of $124k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $236.51 | 28 | $7K | 5.3% |
| 2 | $238.33 | 22 | $5K | 4.2% |
| 3 | $239.18 | 23 | $6K | 4.4% |
| 4 | $240.32 | 50 | $12K | 9.7% |
| 5 | $241.51 | 82 | $20K | 16.0% |
| 6 | $242.44 | 192 |
| $47K |
| 37.5% |
| 7 | $243.23 | 78 | $19K | 15.3% |
| 8 | $244.11 | 38 | $9K | 7.5% |
| Total | $241.68 avg | 513 | $124K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |